List view / Grid view
21 March 2017 | By Kaspar van den Dries PhD, Senior Director and Principal Scientist, Solid Dose Development, Patheon
Patheon's Kaspar van den Dries shows the advantages of considering lipid formulation in early development to optimise a molecule’s developability...
4 October 2016 | By Niamh Louise Marriott, Digital Content Producer
The study met its primary objective which was to determine if 1200mg/day of BC1054 lipid formulated ibuprofen was non-inferior to standard soft gel ibuprofen capsules...
19 September 2016 | By ABITEC Corporation
ABITEC Corporation continues to add new innovations and dosage form applications to their already expansive product portfolio...
17 September 2015 | By Victoria White
LT-02 is a novel barrier function therapy for patients with mild-to-moderate ulcerative colitis...
